Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pauline Busisiwe Nkosi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In Vitro Perspective on Hypofractionated Radiotherapy in Breast Cancer

    by Peter du Plessis, Pauline Busisiwe Nkosi, Shankari Nair, John Akudugu

    Breast cancer remains a major global health challenge, with treatment access further constrained during the COVID-19 pandemic, particularly in resource-limited settings. This study evaluates the in vitro effects of hypofractionated versus conventionally fractionated radiotherapy on three breast cell lines: MCF-7 (oestrogen receptor-positive, ER+/PR+), MDA-MB-231 (triple-negative: ER−/PR−/HER2−), and MCF-10A (non-tumorigenic mammary epithelial). Cells were exposed to cobalt-60 γ-rays, and radiobiological endpoints assessed included clonogenic survival, α/β ratios, adaptive responses, migration, invasion, and cytotoxicity through lactate dehydrogenase assays. The α/β ratios ranged from 2.5 to 5.4 Gy across breast cancer subtypes. Hypofractionation reduced survival in hormone receptor-positive cells, whereas triple-negative cells exhibited increased survival. Adaptive radiation responses enhanced viability across all cell lines, while non-cancerous MCF-10A cells demonstrated reduced migration following treatment. These findings suggest that hypofractionated radiotherapy may be beneficial in hormone receptor-positive breast cancer, while triple-negative disease may show a trend toward different responses, although this was not statistically significant (MDA-MB-231, p = 0.290). The results underscore the importance of tailoring fractionation strategies to breast cancer subtype and highlight the translational potential of preclinical radiobiology in guiding personalised radiation oncology approaches.


  • Open Access

    Improving Access to Radiotherapy in Gauteng: A Framework for Equitable Cancer Care

    by Portia N. Ramashia, Pauline B. Nkosi, Thokozani P. Mbonane

    Radiotherapy, a critical component of cancer treatment, faces significant challenges in Gauteng, South Africa. These disparities hinder the achievement of Sustainable Development Goal 3, primarily due to systemic issues, socioeconomic barriers, and limitations within the health system. This article presents the House framework, designed to enhance access to radiotherapy services by integrating the WHO Health Systems framework with the dimensions of access proposed by Penchansky and Thomas. The framework is visually represented as a house, with Policy & Governance as the foundation, WHO building blocks as pillars, and Equitable Cancer Care and Improved Outcomes as the roof. A mixed-methods approach was utilized, combining quantitative data from radiotherapy facilities and qualitative insights from healthcare professionals to identify barriers and potential solutions. Findings indicate significant disparities in resource distribution and accessibility between public and private institutions, compounded by socioeconomic factors like transport costs and lack of awareness. The article discusses innovative proposed framework using the 5As of access as potential solutions. The House framework serves as a valuable tool for policymakers and healthcare providers aiming to improve radiotherapy access and promote equitable cancer care in Gauteng, ultimately working towards reducing disparities in cancer outcomes.


  • Open Access

    Improving Access to Radiotherapy: Exploring Structural Quality Indicators for Radiotherapy in Gauteng Province, South Africa

    by Portia N. Ramashia, Pauline B. Nkosi, Thokozani P. Mbonane

    Background: Radiotherapy is a critical component of effective cancer treatment, yet access remains limited in many low- and middle-income countries, including South Africa. This study explores structural quality indicators influencing radiotherapy access in Gauteng province, a region with a dual public–private healthcare system. Methods: A concurrent triangulation mixed-methods approach using a descriptive cross-sectional study was employed; for the quantitative phase, data from public and private radiotherapy facilities was analysed, and for the qualitative phase, insights were obtained from interviews with the heads of departments and members of three multidisciplinary professions in radiation oncology, namely radiation oncologists, radiation therapists, and medical physicists. Results: Findings reveal stark disparities in radiotherapy access. Gauteng province has only two major public radiotherapy facilities serving a large population, while multiple private facilities exist. The data indicate substantial differences in resource distribution, equipment accessibility, and personnel levels between public and private institutions. Bureaucratic inefficiencies, personnel shortages, and operational limitations in the public sector have surfaced as significant barriers to prompt equitable access to radiotherapy. This research shows the urgent need for focused strategies to address these systemic issues in order to improve access to radiation treatment in Gauteng province. The study’s findings will inform the development of a comprehensive framework to enhance radiotherapy access and contribute to more equitable cancer care delivery in South Africa.


  • Open Access

    Improving Access to Radiotherapy Services in Gauteng: Quantitative Analysis of Key Time Intervals from Diagnosis to Treatment

    by Portia N. Ramashia, Pauline B. Nkosi, Thokozani P. Mbonane

    Background: Timely access to radiotherapy is crucial for optimal cancer treatment outcomes, as delays in receiving treatment can lead to disease progression and decreased chances of survival. Healthcare systems need to prioritise efficient scheduling and coordination of radiotherapy services to ensure patients receive timely care. This study aims to quantitatively analyse the key time intervals in the cancer care continuum, specifically from diagnosis to the start of radiotherapy treatment in Gauteng. Methods: Data from 800 patients treated between January and December 2023 were analysed using a retrospective analysis of patient records from the two public radiotherapy centres in Gauteng Province, one in Johannesburg and the other in Pretoria, focusing on key time intervals in the cancer care continuum. The durations from diagnosis to the commencement of radiotherapy were analysed. Results: The mean duration of the first consultation was 8.32 months, highlighting significant delays in accessing specialised care. This finding is further supported by the average time until a Computed Tomography (CT) simulation, which was 13.38 months, highlighting a considerable delay in treatment planning. Conclusion: This study highlights systemic delays in the Gauteng radiotherapy pathway, highlighting the need for optimisation of referral processes, resource constraints, and strategies to improve cancer care.


  • Open Access

    Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights

    by Peter du Plessis, Pauline Busisiwe Nkosi, Shankari Nair, John Akudugu

    The rising incidence of prostate cancer necessitates innovative treatment approaches, particularly as diseases such as the COVID-19 pandemic can disrupt traditional cancer care. This study aims to evaluate the impact of hypofractionated versus conventionally fractionated radiotherapy on prostate cancer cell lines in vitro. Prostate cancer cell lines (PC-3 and DU-145) were exposed to varying doses of radiation alongside non-cancerous BPH-1 cells. We assessed radiation effects on cell proliferation, viability, colony formation, DNA repair, migration, invasion, and cytotoxicity. The results demonstrated that the prostate cell lines exhibited varying responses, with hypofractionation favourably impacting aggressive PC-3 cells while preserving non-cancerous cells. In contrast, conventional fractionation led to increased invasion and cytotoxicity in both prostate cancerous cell lines. These findings advocate for personalised radiation therapy approaches that enhance treatment efficacy by considering the distinct behaviours of differing prostate cancer subtypes.


  • Open Access

    Barriers to Radiotherapy Access in Sub-Saharan Africa for Patients with Cancer: A Systematic Review

    by Portia N. Ramashia, Pauline B. Nkosi, Thokozani P. Mbonane

    Background: Access to radiotherapy services is critical for effective cancer treatment, yet patients in sub-Saharan Africa face numerous barriers to accessing these services. The region is experiencing a significant increase in cancer cases, with a more than 85% increase in cancer cases reported in the past decade, highlighting the critical role of radiotherapy in enhancing patient prognosis. This systematic review aims to explore the barriers to radiotherapy access in sub-Saharan Africa. The barriers explored will be used to inform the development of the framework to improve access to radiotherapy in the Gauteng provinces, South Africa. Methods: A systematic search of electronic databases was conducted to identify relevant studies published between January 2013 and December 2023. Studies reporting on barriers to radiotherapy access in SSA were included and put into four categories of barriers: health system factors, patient sociodemographic factors, patient factors, and provider factors. Data were synthesised using thematic analysis. Results: This review identifies geographical, financial, cultural, logistical, and systemic barriers to radiotherapy access in sub-Saharan Africa, including limited infrastructure, long travel distances, and inequitable distribution of services. Systemic barriers, including policy gaps and governance issues, also contribute to the inequitable distribution of radiotherapy services in the region. Conclusions: This systematic review highlights the diverse array of barriers to radiotherapy access in sub-Saharan Africa and emphasises the urgent need for targeted interventions to address these challenges.


  • Open Access

    Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In-Vitro Insights

    by Peter du Plessis, Pauline Busisiwe Nkosi, Shankari Nair, John Akudugu

    The rising incidence of prostate cancer necessitates innovative treatment approaches, particularly as diseases like the COVID-19 pandemic can disrupt traditional cancer care. This study aimed to evaluate the impact of hypofractionated versus conventionally fractionated radiotherapy on prostate cancer cell lines in vitro. Prostate cancer cell lines (PC-3 and DU-145) were exposed to varying doses of radiation alongside non-cancerous BPH-1 cells. We assessed radiation effects on cell proliferation, viability, colony formation, DNA repair, migration, invasion, and cytotoxicity. Results demonstrated that the prostate cell lines exhibited varying responses, with hypofractionation favourably impacting aggressive PC-3 cells while preserving non-cancerous cells. In contrast, conventional fractionation led to increased invasion and cytotoxicity in both prostate cancer cell lines. These findings advocate for personalised radiation therapy approaches that enhance treatment efficacy by considering the distinct behaviours of differing prostate cancer subtypes.

  • Open Access

    "Critical issues detrimental to a cooperative cancer treatment:  Perspectives of Radiation oncologists and Raditional Health Practitioners in KwaZulu-Natal, South Africa"

    by Busisiwe Nkosi

    Introduction / Background: The mortality and morbidity as a result of cancer is expected to escalate in the coming decades due to the increase in cancer occurences globally. The most common treatment for cancer provided by the Radiation Oncologists (ROs) is radiation therapy. In developing countries where there are constrained radiotherapy resources, patients consult concurrently with Traditional Health Practitioners (THPs) and Radiation Oncologists (ROs) for cure or relief from the cancer. Consequently, there are interruptions of treatment and patients present with advanced cancer. Studies have shown that cooperative practice in cancer treatment is crucial for continuity of care. However, there is lack of information on critical issues that can be detrimental to a cooperative practice in cancer treatment. The current study explored those issues as perceived by THPs and ROs in KwaZulu-Natal (KZN), South Africa. Methods: A qualitative case study approach was utilised in this study. This is part of a bigger study conducted to develop a framework for a cooperative practice cancer treatment between THPs and ROs in KZN. Five focus group interviews were conducted with 28 THPs who were selected using snowball. Those were the THPs from eight of 11 districts in KZN who were practising and involved in the treatment of cancer. Furthermore, individual interviews were conducted to collect data from four purposively selected ROs employed at public oncology hospitals. Using a framework analysis, data were analysed to identify themes. Results: The THPs were classified as traditional herbalists, diviners and spiritual healers who were involved in the treatment of patients with cancer. On the other hand, four of seven ROs employed at public hospitals, agreed to participate in the study. With regards to issues detrimental to a cooperative cancer treatment, the emergent themes included lack of relationship, team work, respect and trust, communication, patient involvement in treatment decision making, and delays in patient referrals. Discussion: Despite the ROs’ concern about the role of THPs in cancer treatment, both parties are willing to work together. The issues detrimental to a cooperative practice in cancer treatment between THPs and ROs, need to be rectified. The THPs indicated the desire to build a relationship with the ROs. They felt this would allow them to be able to refer patients to the ROs to confirm a diagnosis before commencing treatment, evaluate their treatments, and provide further treatment if their initial treatment was unsuccessful. Conclusion: Based on the findings of the study, it can be concluded that the THPs and ROs should operate as parallel systems but have a working relationship in order to facilitate the movement of cancer patients between them and ensure that there is continuity of care. Furthermore, cooperation can be encouraged through formal government policies, and that a representative for THPs is needed in all government structures associated with cancer treatment.

  • Open Access

    Allopathic medicine practitioners’ experiences with non-disclosure of traditional medicine use

    by Lindiwe Gumede, Pauline B. Nkosi, Maureen N. Sibiya

    Background: A pertinent issue impacting patient treatment outcomes is the nondisclosure of traditional medicine (TM) use to Allopathic medicine practitioners (AMPs). For years, TM has been a controversial practice, with patients often using it alongside allopathic medicine without disclosing their use. It is imperitive to learn and understand the experiences of AMPs regarding the disclosure of TM use in Gauteng province to enable them to provide the best possible treatment outcomes for patients who use TM. Aim: This study aimed to explore the experiences of AMPs regarding non-disclosure of TM use in Gauteng province. Setting: This study was conducted in four district hospitals where outpatient care and services are rendered in Gauteng Province. Methods: An interpretive phenomenological analysis (IPA) design was followed. Fourteen purposefully sampled AMPs participated in face-to-face, one-on-one, and semi-structured interviews. Interpretive phenomenological analysis in Atlas.ti was conducted. Results: Three themes emerged: bedside manner of AMPs; stigmatising TM use; and individual belief systems. The belief of patients’ disclosure hesitancy because of fear of judgment by the AMPs underpinned these themes. Conclusion: Allopathic medicine practitioners are aware that patients who use TM could feel guilty and stigmatised. They acknowledged that patients use TM because of cultural and ethnic reasons, which should not be disregarded. Contribution: The study highlighted that patients do not disclose their TM use because of AMPs’ attitudes, stigmatising TM use, and their prejudices against the cultural beliefs of patients. Allopathic medicine practitioners should establish good communication with patients by providing patient-centred communication to facilitate disclosure of TM use.